Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/Dalfopristin

Citations Over TimeTop 10% of 2001 papers

Abstract

Clinicians caring for patients with vancomycin-resistant Enterococcus faecium (VREF) infections face severe constraints in the selection of treatment. Quinupristin/dalfopristin (Synercid) is active in vitro against VREF, with a MIC(90) of 1.0 microg/mL. We investigated the clinical efficacy and safety of this agent in a multicenter, prospective, noncomparative, emergency-use study of 396 patients. Patients were included if they had signs and symptoms of active infection, including bacteremia of unknown origin, intra-abdominal infection, and skin and skin-structure infection, with no alternative antibiotic therapy available. The mean duration of treatment was 20 days (range, 4-40 days). The clinical response rate was 68.8% in the evaluable subset, and the overall response rate was 65.6%. The most common adverse events related to quinupristin/dalfopristin were arthralgias and myalgias. Related laboratory abnormalities were rare. In this severely ill patient population, quinupristin/dalfopristin was efficacious and demonstrated an acceptable safety profile in the treatment of VREF infection.

Related Papers

• → Emergence of Increased Resistance to Quinupristin/ Dalfopristin During Therapy for Enterococcus faecium Bacteremia(1997)93 cited
• → Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium(1997)27 cited
• → Treatment of Vancomycin-Resistant Enterococcus faecium with RP 59500 (Quinupristin-Dalfopristin) Administered by Intermittent or Continuous Infusion, Alone or in Combination with Doxycycline, in an In Vitro Pharmacodynamic Infection Model with Simulated Endocardial Vegetations(1998)48 cited
• Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.(1998)
• → Comparative in vitro Activity of Vancomycin and Other Antimicrobial Agents against Methicillin-Resistant <i>Staphylococcus aureus</i> and <i>Enterococcus faecium</i> in the Tohoku District of Japan(1998)2 cited